4//SEC Filing
Cavanaugh Sarah 4
Accession 0001415889-23-010042
CIK 0000744218other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:15 PM ET
Size
5.8 KB
Accession
0001415889-23-010042
Insider Transaction Report
Form 4
Cavanaugh Sarah
SVP OF CORP AFFAIRS & ADMIN.
Transactions
- Award
Incentive Stock Option (right to buy)
2023-06-15+75,000→ 75,000 totalExercise: $36.87From: 2024-06-15Exp: 2033-06-15→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 15, 2024 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001709113
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:15 PM ET
- Size
- 5.8 KB